Characterization of New Staphylococcus haemolyticus ST42 Populations in Northern Taiwan

Microb Drug Resist. 2022 Jan;28(1):56-62. doi: 10.1089/mdr.2019.0459. Epub 2021 Sep 2.

Abstract

Introduction: Staphylococcus haemolyticus is an acquired opportunistic pathogen causing nosocomial infections. Our previous studies of S. haemolyticus showed a group of isolates that produced a significantly higher disease severity than the others. Further molecular typing showed that the sequence type (ST) 42 was the major clone among the isolates. The main aim of this study was to characterize ST42. Materials and Methods: Sixty-one and 36 isolates were collected from burn and nonburn patients, respectively. Molecular typing, antibiotic susceptibility assays, and phenotypic characterizations were performed. Results: Thirteen STs, including seven new STs, were established (ST42 to ST48). ST42 was prevalent in burn and nonburn patients, and all the pulsotype C isolates were ST42. Four of the novel STs originated from ST3, suggesting that these clonal lineages evolved locally. ST3 and ST42 showed a significant difference in clindamycin susceptibility; molecular typing showed only one MLST locus variation among seven loci in SH1431, which has been reportedly involved in the regulation of biofilm formation through Zn 2+ binding affinities. Conclusions: Seven novel S. haemolyticus STs were identified; phylogenetic analysis suggested the presence of locally evolved clonal lineages. The predominant ST42 showed weak biofilm formation abilities; other factors that cause the clonal lineage change still need further investigation.

Keywords: SH1431; ST42; Staphylococcus haemolyticus.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Genes, Bacterial
  • Humans
  • Microbial Sensitivity Tests
  • Staphylococcus haemolyticus / drug effects*
  • Staphylococcus haemolyticus / genetics*
  • Taiwan / epidemiology

Substances

  • Anti-Bacterial Agents